[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100457918":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":10,"centralContacts":10,"locations":31,"responsibleParty":57,"collaborators":10,"id":59,"slug":10,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":60,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":10,"studyType":72,"phases":10,"briefSummary":73,"conditions":74,"keywords":81,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Zhejiang Cancer Hospital","OTHER",[8,13,16,19,22],{"label":9,"type":10,"description":10,"interventionNames":11},"Cervix radical BT",null,[12],"Radiation: Brachytherapy",{"label":14,"type":10,"description":10,"interventionNames":15},"Cervix adjuvant BT",[12],{"label":17,"type":10,"description":10,"interventionNames":18},"Cervix palliative BT",[12],{"label":20,"type":10,"description":10,"interventionNames":21},"Uterus BT",[12],{"label":23,"type":10,"description":10,"interventionNames":24},"Other GO cancer BT",[12],[26],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":10},"RADIATION","Brachytherapy","Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy",[14,17,9,23,20],[32],{"facility":5,"status":33,"city":34,"state":35,"zip":36,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Hangzhou","Zhejiang","310022","China",{"type":39,"coordinates":40},"Point",[41,42],120.16142,30.29365,{"lat":42,"lon":41},[45,50,52,55],{"name":46,"role":47,"phone":48,"phoneExt":10,"email":49},"Xiang Zhang","CONTACT","0086-571-88122048","zhangxiang@zjcc.org.cn",{"name":46,"role":51,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"name":53,"role":54,"phone":10,"phoneExt":10,"email":10},"Jianhong Chen","SUB_INVESTIGATOR",{"name":56,"role":54,"phone":10,"phoneExt":10,"email":10},"Yeqiang Tu",{"type":58,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100457918",false,"NCT05242861","Retrospective Study of Brachytherapy","A Retrospective Study of Brachytherapy in Gynecological Cancers","RetroBT","Inclusion Criteria:\n\n* 18 - 80 female\n* Underwent brachytherapy\n* With gynecological cancer\n\nExclusion Criteria:\n\n* Refusal to enter this trial","FEMALE","18 Years","80 Years",{"count":70,"type":71},300,"ESTIMATED","OBSERVATIONAL","Brachytherapy for gynecological cancers will be studied retrospectively.",[28,75,76,77,78,79,80],"Uterine Cervical Neoplasms","Uterine Neoplasms","Vulvar Cancer","Vaginal Cancer","Ovarian Neoplasms","Gynecologic Neoplasm",[28,82,83,78,77,84,85],"Cervical Cancer","Endometrial Cancer","Image Guided","3D Print","2022-02-06",{"date":88,"type":89},"2022-02-16","ACTUAL",{"date":91,"type":71},"2022-02-20",{"date":93,"type":71},"2027-12-31",{"name":5,"class":6},1]